Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020–2025
Author:
Affiliation:
1. Kantar Health, New York, NY, USA
2. Regeneron Pharmaceuticals Inc. – Health Economics & Outcomes Research, Tarrytown, NY, USA
3. Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
Funder
Regeneron Pharmaceuticals, Inc
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1975188
Reference40 articles.
1. GLOBOCAN. Cancer today [Internet]. [cited 2021 Jan 19]. Available from: http://gco.iarc.fr/today/home
2. SEER Cancer Stat Facts [Internet]. SEER. [cited 2021 Feb 1]. Available from: https://seer.cancer.gov/statfacts/index.html
3. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for B-Cell Lymphomas V.4.2020. ©National Comprehensive Cancer Network, Inc. 2021. All rights reserved. [cited 19 Jan 2021]. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
4. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
5. Direct Costs Associated with Relapsed Diffuse Large B-Cell Lymphoma Therapies
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A new digital droplet PCR method for looking at epigenetics in diffuse large B‐cell lymphomas: The role of BMI1, EZH2, and USP22 genes;International Journal of Laboratory Hematology;2024-09-10
2. The impact of trial inclusion criteria on outcomes in DLBCL patients treated with R-CHOP in the first line: a Danish nationwide study;Leukemia & Lymphoma;2024-09-03
3. A Vision Transformer-Based Framework for Knowledge Transfer From Multi-Modal to Mono-Modal Lymphoma Subtyping Models;IEEE Journal of Biomedical and Health Informatics;2024-09
4. Primary intestinal diffuse large B-cell lymphoma: novel insights and clinical perception;Frontiers in Oncology;2024-08-15
5. Identifying relevant factors influencing cancer-related fatigue in patients with diffuse large B-cell lymphoma during chemotherapy;World Journal of Psychiatry;2024-07-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3